Skip to main content
MedCap logo

MedCap — Investor Relations & Filings

Ticker · MCAP ISIN · SE0009160872 LEI · 549300NGO5XAJ6TL8719 ST Financial and insurance activities
Open in API
Filings indexed 167 across all filing types
Latest filing 2020-04-29 Major Shareholding Noti…
Country SE Sweden
Listing ST MCAP

About MedCap

https://medcap.se/en/

MedCap is an investment company that acquires and develops profitable, market-leading niche companies within the life science sector. The group's strategy focuses on long-term ownership of small and medium-sized enterprises, primarily in Northern Europe, with potential for international growth. Operations are organized into three business areas: MedTech, Assistive Tech, and Specialty Pharma. MedCap supports its portfolio companies by providing capital, expertise, experience, and networks to foster their development and expansion.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2020
Major Shareholding Notification Classification · 1% confidence The document is a 'flaggningsmeddelande' (flagging notification) filed with the Swedish Financial Supervisory Authority (Finansinspektionen). It details a change in shareholding by Linc AB in MedCap AB, specifically crossing a 15% threshold to 20%. This type of regulatory disclosure regarding significant share ownership changes is classified as a Major Shareholding Notification.
2020-04-29 Swedish
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document details a change in shareholding percentage for a specific holder (Linc AB) in MedCap AB (publ). It explicitly states the 'Reason for major shareholding notification' and provides 'Before the transaction' and 'After the transaction' figures for shares and voting rights, including the resulting percentage (12.35%). This structure perfectly matches the definition of a Major Shareholding Notification, which is categorized as 'MRQ'. The document is short and contains specific regulatory data points regarding ownership thresholds.
2020-04-22 English
Major Shareholding Notification 2020
Major Shareholding Notification Classification · 1% confidence The document is a 'flaggningsmeddelande' (flagging notification) filed with the Swedish Financial Supervisory Authority (Finansinspektionen). It details a change in shareholding by Linc AB in MedCap AB, specifically noting a decrease in ownership percentage due to a share loan. This falls under the category of a Major Shareholding Notification (MRQ), which tracks changes in significant ownership levels.
2020-04-22 Swedish
MedCap har genomfört en riktad nyemission om cirka 229 miljoner kronor för att skapa beredskap för nya förvärv
Capital/Financing Update Classification · 1% confidence The document is explicitly titled "PRESSMEDDELANDE" (Press Release) dated April 21, 2020. The content details a 'riktad nyemission' (directed new share issue) of approximately 229 million SEK, including the number of shares, the subscription price (170.0 SEK), the discount, and the intended use of proceeds (creating readiness for new acquisitions). This is a clear announcement regarding a capital/financing activity. Based on the definitions, 'Capital/Financing Update' (CAP) is the most appropriate classification, as it directly relates to fundraising and capital structure changes, rather than being a general regulatory filing (RNS) or a report itself.
2020-04-21 Swedish
MedCap avser att genomföra en riktad nyemission
Share Issue/Capital Change Classification · 1% confidence The document is a press release from MedCap AB announcing their intention to conduct a directed share issue (nyemission). It details the purpose of the capital raise, the involvement of financial advisors (ABG Sundal Collier), and the regulatory context (Market Abuse Regulation). Since this document announces a new share issuance and capital structure change, it falls under the 'Share Issue/Capital Change' category.
2020-04-21 Swedish
MedCap offentliggör preliminärt EBITDA-resultat om 31,4 MSEK för första kvartalet 2020
Earnings Release Classification · 1% confidence The document is explicitly titled as a "PRESSMEDDELANDE" (Press Release) dated April 17, 2020, announcing "preliminärt EBITDA-resultat om 31,4 MSEK för första kvartalet 2020" (preliminary EBITDA result of 31.4 MSEK for the first quarter of 2020). This format, providing key financial highlights for a specific period (Q1 2020) immediately following the period end, is characteristic of an Earnings Release (ER). It is not the full, comprehensive report (like an IR or 10-K), nor is it a transcript (CT) or a general announcement about a report (RPA). The document also mentions being subject to the EU Market Abuse Regulation, confirming its nature as a mandatory financial disclosure. Q1 2020
2020-04-17 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.